Bionik Laboratories Corp. (OTCMKTS:BNKL) Files An 8-K Other Events
Item 8.01
Bionik Laboratories Corp. (the “Company”) issued a press release on May 28, 2019, announcing the completion of a landmark Robot Assisted Training for the Upper Limb after Stroke (RATULS) trial utilizing the Company’s InMotion Robotic Therapy Systems. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
| 99.1 | Press Release dated May 28, 2019 |
Bionik Laboratories Corp. Exhibit
EX-99.1 2 tv522504_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Landmark RATULS Research Trial of Robot-Assisted Stroke Therapy Utilizes BIONIK’s InMotion Robotic Therapy Systems Outcomes of trial,…
To view the full exhibit click here
About Bionik Laboratories Corp. (OTCMKTS:BNKL)
Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking.